Nomograms for prognostic risk assessment in glioblastoma multiforme: Applications and limitations

A novel foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling

(2021) Xiao-Yu Guo et al.   Aging-US

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme

(2021) Zhentao Liu et al.   Frontiers in Genetics

Comprehensive In Silico Analysis of a Novel Serum Exosome-Derived Competitive Endogenous RNA Network for Constructing a Prognostic Model for Glioblastoma

(2021) Zihao Wang et al.   Frontiers in Oncology

Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma

(2021) Liang Zhao et al.   Frontiers in Cell and Developmental Biology

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients

(2021) Zewei Tu et al.   Frontiers in Cell and Developmental Biology

A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study

(2021) Nijiati Kudulaiti et al.   BMC Surgery

An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures

(2021) Yang Yang et al.   Frontiers in Neuroscience

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

(2021) Patrick Y Wen et al.   NEURO-ONCOLOGY

A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing

(2021) Fan Fan et al.   CELLULAR ONCOLOGY

Glioblastoma: Emerging Treatments and Novel Trial Designs

(2021) Vincenzo Di Nunno et al.   Cancers

Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum

(2021) Meng Cui et al.   ACTA NEUROCHIRURGICA

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

(2021) Nirav Patil et al.   JOURNAL OF NEURO-ONCOLOGY

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients

(2020) Zhigang Peng et al.   Aging-US

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme

(2020) Yulin Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

(2020) Annette M. Molinaro et al.   JAMA Oncology

Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme

(2020) Guihua Tang et al.   Frontiers in Oncology

RNA-based pharmacotherapy for tumors: From bench to clinic and back

(2020) Xiangping Liang et al.   BIOMEDICINE & PHARMACOTHERAPY

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

(2020) Sue Han et al.   BRITISH JOURNAL OF CANCER

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas

(2020) Hong-Qing Cai et al.   Frontiers in Oncology

Establishment and validation of an immune-based prognostic score model in glioblastoma

(2020) Zhigang Qin et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Systematic identification, development, and validation of prognostic biomarkers involving the tumor‐immune microenvironment for glioblastoma

(2020) Binghao Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas

(2020) Kanish Mirchia et al.   Cancers

The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database

(2020) Hongjian Li et al.   Frontiers in Oncology

Systematic Review of Prognostic Gene Signature in Gastric Cancer Patients

(2020) Longxiang Xie et al.   Frontiers in Bioengineering and Biotechnology

Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma

(2020) Huaijun Chen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Development of a prognostic model of glioma based on immune‑related genes

(2020) Jing-Jing Wang et al.   Oncology Letters

A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors

(2020) Zhe Zhang et al.   Frontiers in Oncology

The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma

(2019) Erik Ladomersky et al.   Frontiers in Pharmacology

A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival

(2019) Xi Zhang et al.   EUROPEAN RADIOLOGY

A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients

(2019) Yulin Wang et al.   Frontiers in Neurology

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients

(2019) Xiangjun Tang et al.   Frontiers in Oncology

Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database

(2019) Jiri Bartek et al.   JOURNAL OF NEURO-ONCOLOGY

Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma

(2019) Xiao Zhu et al.   Cell and Bioscience

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges

(2018) Alireza Mansouri et al.   NEURO-ONCOLOGY

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

(2017) David Capper et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis

(2017) R. H. Dahlrot et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Comparative Assessment of 4 Methods to Analyze MGMT Status in a Series of 121 Glioblastoma Patients

(2017) Chih-Yi Hsu et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme

(2017) Jiangwei Lao et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Nomograms in oncology: more than meets the eye

(2015) Vinod P Balachandran et al.   LANCET ONCOLOGY

Epidemiologic and Molecular Prognostic Review of Glioblastoma

(2014) J. P. Thakkar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide

(2014) Amandine Etcheverry et al.   PLoS One

Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALA-assisted surgery

(2013) C. Roder et al.   EJSO

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

(2013) Shadi Lalezari et al.   NEURO-ONCOLOGY

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

(2012) Consolación Melguizo et al.   Journal of Translational Medicine

Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival

(2010) Christian Ewelt et al.   JOURNAL OF NEURO-ONCOLOGY

Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?

(2009) Faramarz- Allahdini et al.   World Neurosurgery

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY

CTLA-4 Control over Foxp3+ Regulatory T Cell Function

(2008) K. Wing et al.   SCIENCE